Superiority of 18F-FDG PET/CT to 68GA-FAPI PET/CT in Adrenocortical Tumor Imaging

dc.contributor.authorKaplan, Ihsan
dc.contributor.authorCan, Canan
dc.contributor.authorKepenek, Ferat
dc.contributor.authorIbiloglu, Ibrahim
dc.contributor.authorGuzel, Yunus
dc.date.accessioned2024-04-24T17:08:26Z
dc.date.available2024-04-24T17:08:26Z
dc.date.issued2023
dc.departmentDicle Üniversitesien_US
dc.description.abstractF-18-FDG PET/CT was performed to evaluate the response to treatment in a 62-year-old female patient who was operated for adrenocortical carcinoma. High FDG uptake was observed in recurrent lesion in the left adrenal gland site and metastatic lesions. In the Ga-68-FAPI-04 PET/CT study, low FAPI uptake was observed in both recurrences and metastases. In this case, we demonstrated the superiority of F-18-FDG PET/CT over Ga-68-FAPI-04 PET/CT in the evaluation of adrenocortical carcinoma.en_US
dc.identifier.doi10.1097/RLU.0000000000004601
dc.identifier.endpageE309en_US
dc.identifier.issn0363-9762
dc.identifier.issn1536-0229
dc.identifier.issue6en_US
dc.identifier.pmid36754357
dc.identifier.scopus2-s2.0-85158869605
dc.identifier.scopusqualityQ3
dc.identifier.startpageE307en_US
dc.identifier.urihttps://doi.org/10.1097/RLU.0000000000004601
dc.identifier.urihttps://hdl.handle.net/11468/17342
dc.identifier.volume48en_US
dc.identifier.wosWOS:000981780000008
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoenen_US
dc.publisherLippincott Williams & Wilkinsen_US
dc.relation.ispartofClinical Nuclear Medicine
dc.relation.publicationcategoryDiğeren_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectAdrenocortical Carcinomaen_US
dc.subjectFapien_US
dc.subjectFdgen_US
dc.subjectPet/Cten_US
dc.titleSuperiority of 18F-FDG PET/CT to 68GA-FAPI PET/CT in Adrenocortical Tumor Imagingen_US
dc.titleSuperiority of 18F-FDG PET/CT to 68GA-FAPI PET/CT in Adrenocortical Tumor Imaging
dc.typeEditorialen_US

Dosyalar